BNP Paribas Financial Markets
PAVM icon

BNP Paribas Financial Markets’s PAVmed PAVM Stock Holding History

BNP Paribas Financial Markets’s Portfolio PAVM Stock Details PAVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10 Hold
1
– – ﹤0.01% 5768
2025
Q4 		$7 Hold
1
– – ﹤0.01% 5700
2025
Q3 		$13 Hold
1
– – ﹤0.01% 5513
2025
Q2 		$18 Buy
+1
New +$20 ﹤0.01% 5397
2023
Q1 		– Hold
0
– -$49 – 4008
2022
Q4 		– Hold
0
– – – 3974
2022
Q3 		– Sell
-12
Closed -$6.8K – 4655
2022
Q2 		$5.07K Sell
12
-1,352
-99% -$653K ﹤0.01% 3822
2022
Q1 		$810K Sell
1,364
-149
-10% -$111K ﹤0.01% 2456
2021
Q4 		$1.67M Buy
1,513
+1,484
+5,117% +$3.23M ﹤0.01% 2192
2021
Q3 		$110K Buy
29
+23
+383% +$72.5K ﹤0.01% 3235
2021
Q2 		$17.7K Sell
6
-12
-67% -$28.3K ﹤0.01% 3561
2021
Q1 		$36.7K Buy
18
+3
+20% +$4.51K ﹤0.01% 3679
2020
Q4 		$14.5K Sell
15
-3
-17% -$2.57K ﹤0.01% 3891
2020
Q3 		$14.4K Buy
18
+15
+500% +$13.3K ﹤0.01% 3914
2020
Q2 		$2.84K Buy
+3
New +$3K ﹤0.01% 4145

Other funds holding PAVM

TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Carson Wealth (CWM LLC)
Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BNP Paribas Financial Markets's PAVM Position: Q1 2026 in Review

BNP Paribas Financial Markets held its PAVmed (PAVM) position steady in Q1 2026 at 1 share worth $10. The position accounts for ﹤0.01% of the portfolio, ranked #5768.

BNP Paribas Financial Markets first reported a position in PAVM in Q2 2020 and has held it in 13 quarters since. The position peaked at $1.67M in Q4 2021. 20 funds tracked by Wall St. Rank hold PAVM as of Q1 2026.

  • BNP Paribas Financial Markets held 1 share of PAVmed worth $10 as of Q1 2026.
  • BNP Paribas Financial Markets left its PAVmed share count unchanged in Q1 2026.
  • PAVmed made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q1 2026, its #5768 holding.
  • BNP Paribas Financial Markets first reported a position in PAVmed in Q2 2020 and has held it in 13 quarters since.
  • BNP Paribas Financial Markets's PAVmed position peaked at $1.67M in Q4 2021.
  • 20 funds tracked by Wall St. Rank held PAVmed as of Q1 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2026, filed 12 May 2026.